Tonghua Dongbao Pharmaceutical Management
Management criteria checks 3/4
Tonghua Dongbao Pharmaceutical's CEO is Sheng Leng Chun, appointed in May 2020, has a tenure of 4.58 years. directly owns 0.12% of the company’s shares, worth CN¥18.91M. The average tenure of the management team and the board of directors is 4.6 years and 4.6 years respectively.
Key information
Sheng Leng Chun
Chief executive officer
CN¥3.7m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.6yrs |
| CEO ownership | 0.1% |
| Management average tenure | 4.6yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet
Oct 22
Tonghua Dongbao Pharmaceutical Co., Ltd.'s (SHSE:600867) Earnings Haven't Escaped The Attention Of Investors
Sep 30Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings
Sep 06Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates
Sep 05Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)
Aug 22Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet
Jun 19Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet
May 23CEO
Sheng Leng Chun (50 yo)
4.6yrs
Tenure
CN¥3,728,800
Compensation
Mr. Chun Sheng Leng serves as a Director and General Manager since Mach 27, 2024 and served as the Chairman and General Manager at Tonghua Dongbao Pharmaceutical Co., Ltd. since May 7, 2020 until March 27,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4.6yrs | CN¥3.73m | 0.12% CN¥ 19.0m | |
| Chief Accountant | 4.6yrs | CN¥852.40k | no data | |
| Chief Engineer & Deputy GM | 10.8yrs | CN¥527.20k | 0.015% CN¥ 2.4m | |
| Deputy GM & Director | 4.6yrs | CN¥1.17m | 0.014% CN¥ 2.2m | |
| Deputy GM & Director | 4.6yrs | CN¥1.17m | 0.031% CN¥ 5.0m | |
| Deputy General Manager | 3.1yrs | CN¥1.45m | no data | |
| Deputy GM & Board Secretary | 4.5yrs | CN¥992.50k | no data |
4.6yrs
Average Tenure
50yo
Average Age
Experienced Management: 600867's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 10.8yrs | CN¥3.73m | 0.12% CN¥ 19.0m | |
| Deputy GM & Director | 4.6yrs | CN¥1.17m | 0.014% CN¥ 2.2m | |
| Deputy GM & Director | 4.6yrs | CN¥1.17m | 0.031% CN¥ 5.0m | |
| Chairman of the Supervisory Board | 4.3yrs | CN¥1.17m | 0.12% CN¥ 20.0m | |
| Supervisor | 4.6yrs | CN¥173.20k | no data | |
| Director | 4.3yrs | no data | no data | |
| Employee Representative Supervisor | 4.6yrs | no data | no data | |
| Chairman of the Board | 4.6yrs | CN¥173.20k | 0.27% CN¥ 43.9m | |
| Independent Director | 9.4yrs | CN¥100.00k | no data | |
| Independent Director | 2.6yrs | CN¥100.00k | no data | |
| Independent Director | 2.6yrs | CN¥100.00k | no data | |
| Director | 1.3yrs | no data | no data |
4.6yrs
Average Tenure
50yo
Average Age
Experienced Board: 600867's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 16:08 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tonghua Dongbao Pharmaceutical Co., Ltd. is covered by 29 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Kan Li | Chasing Securities |
| Yanyin Zhu | China International Capital Corporation Limited |